Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization

References

• Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet. 1996; 347: 353–7
   PubMed Web of Science ®Google Scholar
• Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, et al. Granulocyte colony-stimulating factor ‘mobilized’ peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood. 1993; 81: 2031–5
   PubMed Web of Science ®Google Scholar
• Watts MJ, Sullivan AM, Jamieson E, Pearce R, Fielding A, Devereux S, et al. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol. 1997; 15: 535–46
   PubMed Web of Science ®Google Scholar
• Haas R, Möhle R, Frühauf S, Goldschmidt H, Witt B, Flentje M, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood. 1994; 83: 3787–94
   PubMed Web of Science ®Google Scholar
• Mendrone A, Araujo Arrais C, Saboya R, Chamone Dde A, Dulley FL. Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients. Transfus Apher Sci. 2008; 39: 187–92
   Google Scholar
• de la Rubia J, Arbona C, de Arriba F, de Canizo C, Brunet S, Zamora C, et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion. 2002; 42: 4–9
   PubMed Web of Science ®Google Scholar
• Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell. 2006; 124: 407–21
   PubMed Web of Science ®Google Scholar
• Tomblyn M, Burns LJ, Blazar B, Wagner J, Lee C, Rogers T, et al. Difficult stem cell mobilization despite adequate CD34(+) cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma. Bone Marrow Transplant. 2007; 40: 111–8
   PubMed Web of Science ®Google Scholar
• Stockerl-Goldstein KE, Reddy SA, Horning SF, Blume KG, Chao NF, Hu WW, et al. Favorable treatment outcome in non-Hodgkin's lymphoma patients with ‘poor’ mobilization of peripheral blood progenitor cells. Biol Blood Marrow Transplant. 2000; 6: 506–12
   PubMed Web of Science ®Google Scholar
• Boeve S, Strupeck J, Creech S, Stiff PJ. Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost. Bone Marrow Transplant. 2004; 33: 997–1003
   PubMed Web of Science ®Google Scholar
• Goterris R, Hernandez-Boluda JC, Teruel A, Gomez C, Lis MJ, Terol MJ, et al. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers. Bone Marrow Transplant. 2005; 36: 847–53
   PubMed Web of Science ®Google Scholar
• Lemoli RM, de Vivo A, Damiani D, Isidori A, Tani M, Bonini A, et al. Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization. Blood. 2003; 102: 1595–600
   Google Scholar
• Liles WC, Rodger E, Broxmeyer HE, Dehner C, Badel K, Calandra G, et al. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion. 2005; 45: 295–300
   PubMed Web of Science ®Google Scholar
• Cashen A, Lopez S, Gao F, Calandra G, MacFarland R, Badel K, et al. A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoeitic progenitor cell mobilization in patients with Hodgkin lymphoma. Biol Blood Marrow Transplant. 2008; 14: 1253–61
   PubMed Web of Science ®Google Scholar
• Stiff P, Micallef I, McCarthy P, Magalhaes-Silverman M, Weisdorf D, Territo M, et al. Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient. Biol Blood Marrow Transplant. 2009; 15: 249–56
   PubMed Web of Science ®Google Scholar
• Calandra G, McCarty J, McGuirk J, Tricot G, Crocker S-A, Badel K, et al. AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplant. 2008; 41: 331–8
   PubMed Web of Science ®Google Scholar
• Fowler, CJ, Dunn, A, Hayes-Lattin, B, Hansen, K, Hansen, L, Lanier, K, , et al. Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience. Bone Marrow Transplant. 2009:1–9, (advance online publication).
   Google Scholar
• Majado MJ, Minguela A, Gonzalez-Garcia C, Salido E, Blanquer M, Funes C, et al. Large-volume-apheresis facilitates autologous transplantation of hematopoietic progenitors in poor mobilizer patients. J Clin Apher. 2009; 24: 12–17
   Google Scholar
• Fruehauf S, Seeger T, Topaly J. Innovative strategies for PBPC mobilization. Cytotherapy. 2005; 7: 438–46
   Web of Science ®Google Scholar
• Kumar S, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Gastineau DA, et al. Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma. Leukemia. 2007; 21: 2035–42
   PubMed Web of Science ®Google Scholar
• Mazumder A, Kaufman J, Niesvizky R, Lonial S, Vesole D, Jagannath S, et al. Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients. Leukemia. 2008; 22: 1280–1
   PubMed Web of Science ®Google Scholar
• Paripati H, Stewart AK, Cabou S, Dueck A, Zepeda VJ, Pirooz N, et al. Compromised stem cell mobilization following induction therapy with lenalidomide in multiple myeloma. Leukemia. 2008; 22: 1282–4
   PubMed Web of Science ®Google Scholar
• Corso A, Caberlon S, Pagnucco G, Klersy C, Zappasodi P, Alessandrino EP, et al. Blood stem cell collections in multiple myeloma: definition of a scoring system. Bone Marrow Transplant. 2000; 26: 283–6
   PubMed Web of Science ®Google Scholar
• Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 2002; 8: 368–76
   PubMed Web of Science ®Google Scholar
• Haylock DN, Nilsson SK. Expansion of umbilical cord blood for clinical transplantation. Curr Stem Cell Res Ther. 2007; 2: 324–35
   Google Scholar
• de Lima M, McMannis J, Gee A, Komanduri K, Couriel D, Andersson BS, et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant. 2008; 41: 771–8
   PubMed Web of Science ®Google Scholar
• Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood. 2007; 110: 3064–70
   PubMed Web of Science ®Google Scholar
• Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, et al. Double unrelated reduced-intensity cord blood transplantation in adults. Biol Bone Marrow Transplant. 2007; 13: 82–9
   PubMed Web of Science ®Google Scholar
• Jaing, TH, Tsay, PK, Lin, TL, Yang, CP, Hung, IJ, Wen, YC, , et al. Pre-freeze and post-thaw characteristics on chimerism patterns in double-unit cord blood transplantation. Pediatr Blood Cancer. 2009;52(4):547–50.
   Google Scholar
• Isola L, Scigliano E, Fruchtman S. Long-term follow-up after allogeneic granulocyte colony-stimulating factor primed bone marrow transplantation. Biol Blood Marrow Transplant. 2000; 6: 428–33
   Google Scholar